Navigation Links
Telik Announces New TRAP Drug Discovery Agreement
Date:11/12/2008

PALO ALTO, Calif., Nov. 12 /PRNewswire-FirstCall/ -- Telik, Inc. (Nasdaq: TELK) announced today an agreement to provide its TRAP(R) drug discovery technology to investigators at the Hospital for Special Surgery (HSS). The Research Division of HSS studies the mechanisms underlying musculoskeletal and autoimmune diseases to discover effective treatments for these disorders. HSS investigators will use Telik's TRAP technology to discover novel compounds that inhibit a key enzyme in cell signaling and migration.

"By efficiently identifying novel small molecules that affect biological targets, Telik's TRAP technology offers a unique opportunity to accelerate our research," said Carl Blobel, M.D., Ph.D., Professor of Medicine, Physiology, and Biophysics, and Director of the Arthritis and Tissue Degeneration Program at HSS. "We are interested in membrane bound enzymes and the biological effects that result from their modulation. Rapidly finding small molecules that inhibit these enzymes could lead to new ways to treat diseases for which there is significant unmet medical need."

"This partnership allows the world-class investigators at HSS to leverage our recent advances in TRAP technology to accelerate the discovery of new therapeutics that target complex and novel biological targets," said Robert Lum, Ph.D., Telik's Vice President of Technology and Preclinical Development.

TRAP technology exploits the principle that drugs act by adhering to and interacting with cellular proteins. Telik has developed a novel computational approach to determine a molecular fingerprint for each of the over three million compounds in its library. TRAP technology uses these molecular fingerprints to rapidly search the library for promising lead m
'/>"/>

SOURCE Telik, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2

Related biology technology :

1. Telik Announces Financial Results for 2008 Third Quarter
2. Telik Announces Top-Line Results From Assist-5 Trial of Telcyta(R) in Combination With Pegylated Liposomal Doxorubicin in Platinum Refractory and Resistant Ovarian Cancer
3. Telik Announces 2008 Third Quarter Financial Release, Conference Call and Webcast
4. Telik Announces Receipt of Nasdaq Notice
5. Teliks Aurora Kinase-VEGFR Dual Inhibitor Program Meets a Preclinical Development Milestone
6. ReceptorBio Announces Diabetes License Agreement With Telik
7. Telik Announces Financial Results For 2008 Second Quarter
8. Telik Announces 2008 Second Quarter Financial Release, Conference Call and Webcast
9. Telik Announces Publication of Diabetes Research in Bioorganic & Medicinal Chemistry Letters
10. Telik Announces Presentation and Webcast at Needham Biotechnology Conference
11. Telik Announces First Quarter 2008 Financial Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/22/2015)... MA (PRWEB) January 22, 2015 zFlo ... is pleased to announce an exciting product from a new ... motion analysis solutions over the past 15 years, with offerings ... Most recently, their 3D IMU system (inertial measurement unit), iSen, ...
(Date:1/22/2015)... 2015 Selexis SA, a serial innovation ... Banks (RCBs) used for drug discovery to commercial manufacturing, ... include Next-Generation Sequencing (NGS) data packages. The ... manufacturing by ensuring the integrity of the gene, validation ...
(Date:1/22/2015)... Jan. 22, 2015   Cypher Genomics, Inc., ... (NASDAQ: SQNM ), the leading molecular ... next generation noninvasive prenatal tests (NIPT). Through this ... called Mantis™, to advance analysis of clinically-relevant fetal ...
(Date:1/22/2015)...  Derma Sciences, Inc. (Nasdaq: DSCI ), ... care, announces that AMNIOEXCEL® and AMNIOMATRIX®, amniotic allografts ... the Premier, Inc. Regenerative Skin Grafting contract portfolio. ... and AMNIOMATRIX® product lines, which continue to be ...
Breaking Biology Technology:3D Motion Capture Just Got Easy 2Selexis Generated Research Cell Banks Now Fully Sequenced Using Next-Generation Sequencing 2Cypher Genomics and Sequenom Announce Development Agreement 2Cypher Genomics and Sequenom Announce Development Agreement 3Cypher Genomics and Sequenom Announce Development Agreement 4Derma Sciences Expands Access of its AMNIOTIC TISSUE Product Line with New Premier, Inc. Agreement 2Derma Sciences Expands Access of its AMNIOTIC TISSUE Product Line with New Premier, Inc. Agreement 3Derma Sciences Expands Access of its AMNIOTIC TISSUE Product Line with New Premier, Inc. Agreement 4Derma Sciences Expands Access of its AMNIOTIC TISSUE Product Line with New Premier, Inc. Agreement 5
... LIVERPOOL, February 2 Gray Healthcare has ... to lead its,expanding Community Recovery Team, as Clinical Director. ... years, experience of senior management in mental,health in both the ... of operations at Cambian Healthcare, covering 12 psychiatric,rehabilitation hospitals, he ...
... SAN DIEGO , Feb. 1 BioMed Realty Trust, Inc. ... its fourth quarter and year ended December 31, 2009 after ... Alan D. Gold , Chairman and Chief Executive Officer, and ... conference call at 10:00 a.m. Pacific Time on Thursday, ...
... Astrogenetix ... Space Station (ISS) to 2020 or beyond. , ... (Vocus) February 1, 2010 -- Astrogenetix is issuing the following statement applauding ... beyond. , ,Thomas B. Pickens III, Chairman of Astrogenetix, Inc.:, , ,“We are excited to ...
Cached Biology Technology:Noel Tracey to Head Up Gray Healthcare Recovery Team 2BioMed Realty Trust to Report 2009 Fourth Quarter and Year-End Results 2Astrogenetix Statement On Nasa's Fiscal Year 2011 Budget Announcement 2
(Date:12/17/2014)... Dec. 16, 2014 Valencell, a leader in performance ... technology to industry leaders such as Intel, Jabra, Atlas, ... biometric wearable products. These products will be showcased at ... Las Vegas . "Our partners ...
(Date:12/11/2014)... , Dec. 09, 2014 Research and Markets ... ( http://www.researchandmarkets.com/research/twhjll/biometrics_market ) has announced the addition of the ... to their offering. One major trend ... continuous advances in technology, it is important to upgrade ...
(Date:12/10/2014)... YORK , Dec. 8, 2014 You,ve been here before: ... can,t remember your password, site key or the answer to your ... teacher? Today, Hoyos Labs , a digital ... put an end to the frustration that comes with usernames, passwords ...
Breaking Biology News(10 mins):Valencell PerformTek Biometrics Power the Most Accurate Wearables at CES 2015 2Biometrics Market in the APAC Region 2015-2019: Key Vendors are 3M Cogent, NEC, Safran and Suprema 2The Password is Finally Dead: Launch of 1U Mobile App Eliminates Need for All Usernames and Passwords 2The Password is Finally Dead: Launch of 1U Mobile App Eliminates Need for All Usernames and Passwords 3
... existed in the Amazon before the arrival of Europeans, ... the result of research led by Crystal McMichael and ... The finding overturns the idea the Amazon was a ... that transformed vast tracts of the landscape. The ...
... vegetarian and ecological products, but is it really making ... about ethical trade, Gothenburg researchers Bengt Brlde and ... help ease people,s bad conscience, it does nothing to ... fixing the problem will require collective solutions, such as ...
... UC Santa Barbara scientists turned to the simple sponge to ... and found that, but for a mechanism that coordinates the ... synapses, sponges and the rest of the animal world may ... of a protosynaptic gene expression network," are published in the ...
Cached Biology News:Scientists reconstruct pre-Columbian human effects on the Amazon Basin 2Ethical trade: 'Good intentions go to waste' 2Clues to nervous system evolution found in nerve-less sponge 2
... Polyclonal Phosphorylated Anti-GluR1 Glutamate is the ... many years it had been considered to ... NMDA, AMPA and kainate receptors that are ... Recently, glutamate has been shown to regulate ...
Anti-ADP-Ribosylation Factor 1, clone 3F1 Immunogen: Synthetic peptide corresponding to the C-terminal amino acid sequence of human ARF1. Available Date: 38495...
TNF-Related Apoptosis Inducing Ligand-Receptor-1...
Pim-1 (12H8)...
Biology Products: